Related Experiment Video
Updated: Oct 17, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Impaired Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
Urszula Gancarczyk1,2, Andrea Stefanini3, Paweł Prochownik4
1Department of Transplantology and Mechanical Circulatory Support, Krakow Specialist Hospital Named After St. John Paul II, ul. Prądnicka 80, 31-202 Kraków, Poland.
Abstract:
Background/Objectives: Embolic Stroke of Undetermined Source (ESUS) refers to non-lacunar ischemic stroke without an identified cause and is presumed to be related to a cardioembolic mechanism. A potential etiological factor is atrial fibrosis leading to left atrial (LA) dysfunction, also known as atrial cardiomyopathy. This study aimed to compare advanced transthoracic echocardiographic parameters of LA function in patients with ESUS and age- and sex-matched controls. Methods: In this prospective matched observational case-control study, fifty patients with ESUS and 50 age- and sex-matched controls were analyzed. All participants underwent comprehensive transthoracic echocardiography (TTE). LA parameters included four-dimensional volumetry, LA strain (LAS), and LA stiffness index calculated as the ratio of E/e' to reservoir strain. All ESUS patients additionally underwent transesophageal echocardiography (TEE) to assess the presence of patent foramen ovale (PFO). Results: Compared with controls, ESUS patients had significantly reduced LAS in the reservoir phase (LAS-r 37.3% vs. 42.3%; p < 0.01) and conduit phase (LAS-cd 22.9% vs. 28.4%; p < 0.01), as well as a higher LA stiffness index (0.171 vs. 0.149; p < 0.01). No significant differences were found in LA size or volume. In subgroup analysis, ESUS patients with and without PFO did not differ, while both subgroups showed significant impairment compared with controls. Conclusions: ESUS is associated with impaired LA functional properties despite preserved LA size. LAS may provide complementary information on subclinical LA functional abnormalities in patients with ESUS; however, its clinical and prognostic significance requires validation in prospective studies.
Related Concept Videos
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Pulmonary Embolism I: Introduction
Ischemic Stroke ll: Pathophysiology